Učitavanje...
Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening
Protein arginine methyltransferase 5 (PRMT5) is able to regulate gene transcription by catalyzing the symmetrical dimethylation of arginine residue of histone, which plays a key role in tumorigenesis. Many efforts have been taken in discovering small-molecular inhibitors against PRMT5, but very few...
Spremljeno u:
Izdano u: | Front Pharmacol |
---|---|
Glavni autori: | , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Frontiers Media S.A.
2018
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5838003/ https://ncbi.nlm.nih.gov/pubmed/29545752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00173 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|